J. Alex Taylor, Ph.D., Scientist IV, Molecular Design Group, Just Biotherapeutics
Just Biotherapeutics was formed with the goal of inventing and internally applying the technologies required to drastically reduce the cost of biotherapeutic development and manufacturing. To realize this goal we must measure and capture all aspects of our development process from molecular properties through production characteristics. LabKey Biologics enables this registration and data capture across a wide variety of biopharmaceutical steps and also enables high throughput, plate-based automation efforts. Utilizing a combination of structured data and full entity and sample lineages we are able to build predictive models which allow us to refine our processes to expand capacity and shorten development times, resulting in lower cost biotherapeutics for the world.